Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 28.76% vs -11.83% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 121.40% vs -32.46% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 17.69% vs 97.09% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 146.45% vs -15.94% in Mar 2024
Compare Profit and Loss Results of Jagsonpal Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
268.00
370.00
-102.00
-27.57%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
268.00
370.00
-102.00
-27.57%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
1.00
-3.00
-300.00%
Raw Materials Consumed
98.00
181.00
-83.00
-45.86%
Power & Fuel Cost
0.00
23.00
-23.00
-100.00%
Employee Cost
70.00
43.00
27.00
62.79%
Operating Expenses
0.00
3.00
-3.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
16.00
8.00
50.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
217.00
289.00
-72.00
-24.91%
Operating Profit (PBDIT) excl Other Income
51.00
80.00
-29.00
-36.25%
Other Income
8.00
1.00
7.00
700.00%
Operating Profit (PBDIT)
59.00
82.00
-23.00
-28.05%
Interest
0.00
9.00
-9.00
-100.00%
Profit before Depriciation and Tax
58.00
72.00
-14.00
-19.44%
Depreciation
8.00
18.00
-10.00
-55.56%
Profit Before Taxation & Exceptional Items
50.00
54.00
-4.00
-7.41%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
69.00
54.00
15.00
27.78%
Provision for Tax
14.00
14.00
0.00
0.00%
Profit After Tax
55.00
39.00
16.00
41.03%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
104.00
206.00
-102.00
-49.51%
Profit Available for appropriations
159.00
246.00
-87.00
-35.37%
Appropriations
159.00
246.00
-87.00
-35.37%
Equity Dividend (%)
125%
0%
125.00
Earnings Per Share
8.26
38.44
-30.18
-78.51%
Profit And Loss - Net Sales
Net Sales 268.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.76% vs -11.83% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.07 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 121.40% vs -32.46% in Mar 2024
Profit And Loss - Interest
Interest 0.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.69% vs 97.09% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 55.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 146.45% vs -15.94% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
